Lauren Cummins & Marshall E. Cates, P. (2022). Istradefylline: A novel agent in the treatment of "off" episodes associated with levodopa/carbidopa use in Parkinson disease. American Association of Psychiatric Pharmacists.
Chicago Style (17th ed.) CitationLauren Cummins and PharmD Marshall E. Cates. Istradefylline: A Novel Agent in the Treatment of "off" Episodes Associated with Levodopa/carbidopa Use in Parkinson Disease. American Association of Psychiatric Pharmacists, 2022.
MLA (9th ed.) CitationLauren Cummins and PharmD Marshall E. Cates. Istradefylline: A Novel Agent in the Treatment of "off" Episodes Associated with Levodopa/carbidopa Use in Parkinson Disease. American Association of Psychiatric Pharmacists, 2022.
Warning: These citations may not always be 100% accurate.